1. Home
  2. AUPH vs CDRE Comparison

AUPH vs CDRE Comparison

Compare AUPH & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
    SELLHOLDBUYas of an hour ago
  • CDRE
    SELLHOLDBUYas of an hour ago
  • Stock Information
  • Founded
  • AUPH 1993
  • CDRE 2012
  • Country
  • AUPH Canada
  • CDRE United States
  • Employees
  • AUPH N/A
  • CDRE N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • CDRE Industrial Specialties
  • Sector
  • AUPH Health Care
  • CDRE Health Care
  • Exchange
  • AUPH Nasdaq
  • CDRE Nasdaq
  • Market Cap
  • AUPH 1.1B
  • CDRE 1.4B
  • IPO Year
  • AUPH 1999
  • CDRE 2021
  • Fundamental
  • Price
  • AUPH $8.01
  • CDRE $28.90
  • Analyst Decision
  • AUPH Strong Buy
  • CDRE Strong Buy
  • Analyst Count
  • AUPH 2
  • CDRE 1
  • Target Price
  • AUPH $11.50
  • CDRE $37.00
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • CDRE 306.1K
  • Earning Date
  • AUPH 05-01-2025
  • CDRE 05-06-2025
  • Dividend Yield
  • AUPH N/A
  • CDRE 1.26%
  • EPS Growth
  • AUPH N/A
  • CDRE N/A
  • EPS
  • AUPH 0.04
  • CDRE 0.90
  • Revenue
  • AUPH $235,133,000.00
  • CDRE $567,561,000.00
  • Revenue This Year
  • AUPH $11.86
  • CDRE $8.19
  • Revenue Next Year
  • AUPH $24.96
  • CDRE $8.18
  • P/E Ratio
  • AUPH $204.13
  • CDRE $33.52
  • Revenue Growth
  • AUPH 33.97
  • CDRE 17.62
  • 52 Week Low
  • AUPH $4.71
  • CDRE $28.74
  • 52 Week High
  • AUPH $10.67
  • CDRE $40.28
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 45.28
  • CDRE 35.43
  • Support Level
  • AUPH $7.93
  • CDRE $28.98
  • Resistance Level
  • AUPH $8.73
  • CDRE $30.56
  • Average True Range (ATR)
  • AUPH 0.23
  • CDRE 1.08
  • MACD
  • AUPH -0.05
  • CDRE -0.15
  • Stochastic Oscillator
  • AUPH 20.00
  • CDRE 13.74

Stock Price Comparison Chart: AUPH vs CDRE

AUPH
CDRE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April051015202530354045AUPH VS CDRE

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use